Synthesis of deuterium-labeled tetrahydrocortisol and tetrahydrocortisone for study of cortisol metabolism in humans

Steroids

Volumn 64, Issue 12, 1999, Pages 805-811

  Furuta, Takashi ^a   Namekawa, Toshiyuki ^a   Shibasaki, Hiromi ^a   Kasuya, Yasuji ^a  

^a TOKYO UNIVERSITY OF PHARMACY AND LIFE SCIENCES   (Japan)

Author keywords

Catalytic reduction; Cortisol metabolism; Deuterium labeled steroids; Mass spectrometry; Tetrahydrocortisol; Tetrahydrocortisone

Indexed keywords

DEUTERIUM; HYDROCORTISONE; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

ARTICLE; CATALYSIS; DRUG SYNTHESIS; ISOTOPE LABELING; MASS SPECTROMETRY; REACTION ANALYSIS; STEROIDOGENESIS;

CHROMATOGRAPHY, LIQUID; DEUTERIUM; HUMANS; HYDROCORTISONE; ISOTOPE LABELING; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; TETRAHYDROCORTISOL; TETRAHYDROCORTISONE;

EID: 0032712932     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(99)00056-2     Document Type: Article

References (18)

1. Ulick S., Tedde R., Mantero F. Pathogenesis of the type 2 variant of the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 70:1990;200-206.
2. Ulick S., Tedde R., Wang J.Z. Defective ring A reduction of cortisol as the major metabolic error in the syndrome of apparent mineralocorticoid excess. J Clin Endocrinol Metab. 74:1992;593-599.
3. Stewart P.M., Whorwood C.B., Walker B.R. Steroid hormone and hypertension the cortisol-cortisone shuttle . Steroids. 58:1993;614-620.
4. Mantero F., Tedde R., Opocher G., Fulgheri P.D., Arnaldi G., Ulick S. Apparent mineralocorticoid excess type II. Steroids. 59:1994;80-83.
5. Stewart P.M., Whorwood C.B., Mason J.I. Type 2 11β-hydroxysteroid dehydrogenase in foetal and adult life. J Steroid Biochem Mol Biol. 55:1995;465-471.
6. Funder J.W. Apparent mineralocorticoid excess. Endocrinol Metab Clin North Am. 24:1995;613-621.
7. Mantero F., Palermo M., Petrelli M.D., Tedde R., Stewart P.M., Shackleton C.H.L. Apparent mineralocorticoid excess type I and type II . Steroids. 61:1996;193-196.
8. Shackleton C.H.L., Chai W. Mass spectrometry application to steroid and peptide research . Endocr Rev. 6:1985;441-486.
9. Minagawa M., Furuta T., Kasuya Y., Fujino A., Avery M.A., Tanabe M. Total synthesis of cortisol application to selective deuteriation at C-1 and C-19 . J Chem Soc Perkin Trans. 1:1988;587-591.
10. Shibasaki H., Arai I., Furuta T., Kasuya Y. Simultaneous determination of cortisol and cortisone in human plasma by stable isotope dilution mass spectrometry. J Chromatogr. 576:1992;47-52.
11. Shibasaki H., Furuta T., Kasuya Y. Stable isotope dilution mass spectrometry for the simultaneous determination of cortisol, cortisone, prednisolone and prednisone in plasma. J Chromatogr. 579:1992;193-202.
12. Shibasaki H., Furuta T., Kasuya Y. Quantification of corticosteroids in human plasma by liquid chromatography-thermospray-mass spectrometry using stable isotope dilution. J Chromatogr B. 692:1997;7-14.
13. Kasuya Y., Iwano M., Shibasaki H., Furuta T. Pharmacokinetic studies of cortisol after oral administration of deuterium-labelled cortisol to a normal human subject. J Mass Spectrom Rapid Comm Mass Spectrom. 1995;s29-s34.
14. Kasuya Y., Ishimaru H., Shibasaki H., Furuta T. Stable isotope methodology for kinetic studies of interconversion of cortisol and cortisone in a human subject. Steroids. 63:1998;122-129.
15. Caspi E. Degradation of corticosteroids. III. Catalytic hydrogenation of cortisol. J Org Chem. 24:1959;669-673.
16. Pataki J., Rosenkranz G., Djerassi C. Steroids XXX. Partial synthesis of allopregnane-3β,11β,21-triol-20-one and allopregnane-3β,11β,17α,21-tetrol-20-one. J Biol Chem. 195:1952;751-754.
17. Brodie H.J., Hayano M., Gut M. The stereochemical course of the catalytic hydrogenation of ring A unsaturated steroids. J Am Chem Soc. 84:1962;3766-3767.
18. Furuta T., Namekawa T., Shibasaki H., Kasuya Y. Simultaneous determination of tetrahydrocortisol and tetrahydrocortisone in human plasma and urine by stable isotope dilution mass spectrometry. J Chromatogr Biomed Appl. 706:1998;181-190.